Experimental and Clinical Hematology Program PHEC
Acute lymphoblastic leukemia (ALL)

José María Ribera
Position at Josep Carreras Institute:
Group leaderBarcelona Endothelium Team (BET)

Enric Carreras
Position at Josep Carreras Institute:
Group leaderMyeloid neoplasms

Lurdes Zamora
Position at Josep Carreras Institute:
Group leaderImmunohematology and glycobiology

Fumiichiro Yamamoto
Position at Josep Carreras Institute:
Group leaderLymphoid neoplasms

Tomás Navarro
Position at Josep Carreras Institute:
Group leaderMultiple myeloma

Albert Oriol
Position at Josep Carreras Institute:
Group leaderMyelodysplastic syndromes

Francesc Solé
Position at Josep Carreras Institute:
Group leaderStem cell biology, developmental leukemia and immunotherapy

Pablo Menéndez
Position at Josep Carreras Institute:
Group leaderStem cell transplantation and cellular Immunotherapy

Álvaro Urbano-Ispizua
Position at Josep Carreras Institute:
Group leaderEpigenetic therapies

María Berdasco
Position at Josep Carreras Institute:
Group leaderLymphoma translational group

Gaël Roué
Position at Josep Carreras Institute:
Group leaderOncogenesis and antitumor drugs

Ramon Mangues
Position at Josep Carreras Institute:
Group leaderChronic lymphocytic leukemia

Carolina Moreno
Position at Josep Carreras Institute:
Group leaderHematological diseases, transplant, and cell therapy

Jordi Sierra
Position at Josep Carreras Institute:
Group leaderMyeloid neoplasms - Clínic

Jordi Esteve Reyner
Position at Josep Carreras Institute:
Group leaderHematology

David Gallardo
Position at Josep Carreras Institute:
Group leaderDescriptive epidemiology, genetics and cancer prevention

Rafael Marcos-Gragera
Position at Josep Carreras Institute:
Group leaderCellular immunotherapy and gene therapy group

Javier Briones
Position at Josep Carreras Institute:
Group leaderHematological diagnosis

Josep Nomdedéu